Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolin Rippke

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical and Translational Radiation Oncology|March 20, 2023
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at riskPhilipp Hoegen, Efthimios Katsigiannopulos, Carolin Buchele, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2022
SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomesSebastian Regnery, Carolin Buchele, Lars Piskorski, et al.
Frontiers in Oncology|January 28, 2022
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk LocationsSebastian Regnery, Carolin Buchele, Fabian Weykamp, et al.
Cancers|December 23, 2022
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver MetastasesFabian Weykamp, Efthimios Katsigiannopulos, Lars Piskorski, et al.
Radiation Oncology (London, England)|May 29, 2023
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapySebastian Regnery, Lukas Leiner, Carolin Buchele, et al.
Cancers|June 27, 2024
Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single InstitutionPhilipp Hoegen-Saßmannshausen, Inga Jessen, Carolin Buchele, et al.
Frontiers in Oncology|March 1, 2024
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancerChristoph A Fink, Carolin Buchele, Lukas Baumann, et al.
Clinical and Translational Radiation Oncology|January 10, 2025
How to protect the proximal bronchial tree during stereotactic radiotherapy of ultracentral lung tumors: Lessons from MR-guided treatmentSebastian Regnery, Efthimios Katsigiannopulos, Hin Lau, et al.
Radiation Oncology (London, England)|May 25, 2022
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)Sebastian Regnery, Jonas Ristau, Fabian Weykamp, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2023
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomesSebastian Regnery, Efthimios Katsigiannopulos, Philipp Hoegen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical and Translational Radiation Oncology|March 20, 2023
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at riskPhilipp Hoegen, Efthimios Katsigiannopulos, Carolin Buchele, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2022
SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomesSebastian Regnery, Carolin Buchele, Lars Piskorski, et al.
Frontiers in Oncology|January 28, 2022
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk LocationsSebastian Regnery, Carolin Buchele, Fabian Weykamp, et al.
Cancers|December 23, 2022
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver MetastasesFabian Weykamp, Efthimios Katsigiannopulos, Lars Piskorski, et al.
Radiation Oncology (London, England)|May 29, 2023
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapySebastian Regnery, Lukas Leiner, Carolin Buchele, et al.
Cancers|June 27, 2024
Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single InstitutionPhilipp Hoegen-Saßmannshausen, Inga Jessen, Carolin Buchele, et al.
Frontiers in Oncology|March 1, 2024
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancerChristoph A Fink, Carolin Buchele, Lukas Baumann, et al.
Clinical and Translational Radiation Oncology|January 10, 2025
How to protect the proximal bronchial tree during stereotactic radiotherapy of ultracentral lung tumors: Lessons from MR-guided treatmentSebastian Regnery, Efthimios Katsigiannopulos, Hin Lau, et al.
Radiation Oncology (London, England)|May 25, 2022
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)Sebastian Regnery, Jonas Ristau, Fabian Weykamp, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2023
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomesSebastian Regnery, Efthimios Katsigiannopulos, Philipp Hoegen, et al.
Pageof 3